ACZ ACN 01. A phase 4, double-blind, multicenter, randomized, vehicle-controlled, cross-over study to further evaluate the risk of hematological adverse events in G6PD [glucose-6-phosphate dehydrogenase]-deficient subjects with acne vulgaris treated with ACZONE dapsone) gel, 5%

Trial Profile

ACZ ACN 01. A phase 4, double-blind, multicenter, randomized, vehicle-controlled, cross-over study to further evaluate the risk of hematological adverse events in G6PD [glucose-6-phosphate dehydrogenase]-deficient subjects with acne vulgaris treated with ACZONE dapsone) gel, 5%

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 May 2011

At a glance

  • Drugs Dapsone (Primary)
  • Indications Acne vulgaris
  • Focus Adverse reactions; Registrational
  • Most Recent Events

    • 23 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top